Emergency department waiting times for patients with cancer with febrile neutropenia: a pilot study

Oncology Nursing Forum
Anita NirenbergElaine Larson

Abstract

To determine the time frame for evaluation and treatment of adult patients with febrile neutropenia in the emergency department (ED). Prospective, descriptive survey. ED in a large, urban, academic health center. 19 patients with febrile neutropenia during 23 ED visits in eight months. Demographic and treatment variables and durations of time were recorded from ED and medical records. Patients had fevers a mean of 21 hours (range = 1-72 hours) before seeking treatment. Median waiting time from ED admission to examination was 75 minutes, 210 minutes before antibiotics were given, and 5.5 hours to hospital admission. Patients with more comorbidities and more extensive cancer waited significantly longer than those at lower risk (p less than 0.002). Although the standard of care is to treat febrile neutropenia as an oncologic emergency, patients waited prolonged periods prior to receiving treatment. Studies are indicated to examine early intervention for febrile neutropenia and to determine whether early intervention improves clinical outcomes. Nurses may repeat this study at other settings and with other populations of people with cancer. Other studies may provide evidence that clinical outcomes are dependent on rapid intervention...Continue Reading

References

Feb 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J A TalcottL Goldman
Jul 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J H SilberK R Fox
Aug 26, 1999·Seminars in Oncology Nursing·B K Shelton
Oct 26, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·K V Rolston
Aug 16, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J KlasterskyJ Talcott
Oct 14, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H OzerUNKNOWN American Society of Clinical Oncology
Oct 29, 2000·International Journal of Antimicrobial Agents·M Paesmans
Jan 4, 2001·Journal of the National Cancer Institute·R García-CarboneroL Paz-Ares
Jun 2, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T J Smith, B E Hillner
Feb 19, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Walter T HughesLowell S Young
Mar 21, 2002·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Graeme N ForrestAlan Cross
Mar 21, 2002·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Linda S Elting, Scott B Cantor
May 25, 2002·Cancer Investigation·Andrew Koh, Philip A Pizzo

❮ Previous
Next ❯

Citations

Apr 25, 2012·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Amanda Digel VandykDawn Stacey
Apr 11, 2014·BMC Health Services Research·Thomas PerronShahid Ahmed
Jul 9, 2013·Critical Care Clinics·Eric J Bow
Oct 30, 2010·The American Journal of Emergency Medicine·Charles LimBrian H Rowe
Jun 13, 2015·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Samantha Gibson, Ruth McConigley
Aug 19, 2009·Journal of Clinical Nursing·Julie ConsidineMari Botti
Nov 20, 2008·British Journal of Haematology·Simon RichardsonTimothy Littlewood
Mar 23, 2011·Pediatrics International : Official Journal of the Japan Pediatric Society·Samart PakakasamaSuradej Hongeng
Dec 7, 2006·Oncology Nursing Forum·Anita NirenbergRobert David Rice
Aug 12, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Barry MeisenbergMary Clance
Oct 28, 2016·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Lorraine WarringtonGalina Velikova
Oct 28, 2016·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Graeme MattisonTim Cooksley
Jun 15, 2014·Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses·Lindsay MizeMarilyn Hockenberry
Dec 24, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·A VediR J Cohn
Aug 13, 2010·Western Journal of Nursing Research·Vicki S ConnJean F Wyman
Feb 11, 2020·International Journal of Laboratory Hematology·Dår K KurLennart Friis-Hansen
Oct 13, 2011·Revista gaúcha de enfermagem·Nádia Fontoura SanhudoVilma de Carvalho
Jun 11, 2020·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Marika RasschaertMarc Peeters
Mar 12, 2021·International Emergency Nursing·Anas Alsharawneh, Abd Al-Hadi Hasan
May 6, 2021·Revista brasileira de enfermagem·Rosilene Aparecida Costa AmaralKelli Borges Dos Santos
Sep 1, 2021·Seminars in Oncology Nursing·Anas Alsharawneh, Joy Maddigan
Aug 21, 2020·Oncology Research and Treatment·João Moreira-PintoJosé Luís Passos-Coelho

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.